1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency & Pricing
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 28)
4.1 Lucrative Opportunities in the 3D Cell Culture Market

5 Market Overview (Page No. – 31)
5.1 Introduction
5.2 Market Segmentation
5.2.1 Regenerative Medicines Market Segmentation, By Technology
5.2.2 Regenerative Medicines Market Segmentation, By Application
5.2.3 Regenerative Medicines Market Segmentation, By End User
5.3 Market Dynamics
5.4 Drivers
5.4.1 Rising Investment in Research Related Activities
5.4.2 Technological Advancements
5.4.3 Funding for Cell Based Research
5.5 Restraints
5.5.1 High Cost of Cell Biology Research
5.5.2 Lack of Infrastructure for Cell Based Research in Emergeing Countries
5.6 Opportunities
5.6.1 Rising Demand for Organ Transplantation
5.6.2 Increase in R&D Spending
5.7 Challenges
5.7.1 Lack of Consistency in 3D Cell Culture Products

6 Global 3D Cell Culture Market, By Technology (Page No. – 40)
6.1 Introduction
6.2 Scaffold Based
6.2.1 Hydrogels/Ecm Analogs
6.2.2 Solid Scaffolds
6.2.3 Micropatterened Surfaces
6.3 Scaffold Free
6.3.1 Hanging Drop Plates
6.3.2 3-D Bioreactors
6.3.3 Magnetic Levitations & 3D Bioprinting
6.3.4 Microfluidics
6.3.5 Ultra-Low Attachment Plates
6.3.6 3-D Petrisidhes

7 Global 3D Cell Culture Market, By Application (Page No. – 50)
7.1 Introduction
7.2 Cancer Cell Research
7.3 Cell Based Assays/Toxicity Screening
7.4 Regenerative Medicine/Tissue Engineering
7.5 In Vivo Applications for Stem Cells
7.6 3D Printing/Microfluidics
7.7 Others

8 Global 3D Cell Culture Market, By End User (Page No. – 58)
8.1 Introduction
8.2 Biotechnology and Pharmaceutical Industries
8.3 Research Laboratories
8.4 Hospitals and Diagnostic Centers
8.5 Others

9 Global 3D Cell Culture Market, By Region (Page No. – 71)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe (RoE)
9.4 Asia-Pacific
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 126)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.3.1 New Product Launches
10.3.2 Acquisitions
10.3.3 Regulatory Approvals
10.3.4 Partnerships

11 Company Profile (Page No. – 133)
(Overview, Financial*, Products & Services, Strategy, and Developments)
11.1 Introduction
11.2 Thermo Fisher Scientific
11.3 BD
11.4 Corning Incorporated
11.5 Lonza AG
11.6 Sigma-Aldrich Co.LLC.
11.7 Hi Media Laboratories
11.8 Promocell GmbH
11.9 3D Biotek LLC.
11.10 Bell Brook Labs.
11.11 Kurray Co.Ltd
11.12 Global Cell Solutions

*Details Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 153)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Available Customizations
12.6 Related Reports

List of Tables (66 Tables)

Table 1 Global 3D Cell Culture Market Size, By Technology, 2014–2021 (USD Billion)
Table 2 Market Size, By Technology, 2014-2021 (USD Million)
Table 3 Scaffold Based Market Size, By Technology, 2014-2021 (USD Million)
Table 4 Scaffold Based Market Size By Region
Table 5 Hydrogels/Ecm Analogs Market Size By Region, 2014-2021 (USD Million)
Table 6 Solid Scaffold Market Size, By Region
Table 7 Micropatterened Surfaces Market Size, By Region, 2014-2021 (USD Million)
Table 8 Scaffold Free Market Size, By Technology, 2014-2021 (USD Million)
Table 9 Scaffold Free Market Size, By Region, 2014-2021 (USD Million)
Table 10 Ultra-Low Attachemnet Plates Market Size, By Region, 2014-2021 (USD Million)
Table 11 3D Petri Dishes Market, By Region, 2014-2021 (USD Million)
Table 12 Microfluidics Market, By Region, 2014-2021 (USD Million)
Table 13 Hanging Drop Plates Market, By Region, 2014-2021 (USD Million)
Table 14 3-D Bioreactors Market, By Region, 2014-2021 (USD Million)
Table 15 Magnetic Levitation and 3-D Bioprinting Market, By Region, 2014-2021 (USD Million)
Table 16 Cancer Cell Culture Market, By Region, 2014-2021 (USD Million)
Table 17 Cell Based Assay/Toxicity Screening Market Size, By Region, 2014-2021 (USD Million)
Table 18 Regenrative Medicine/Tissue Engineering Market Size, By Region, 2014-2021 (USD Million)
Table 19 Others Market, By Region, 2014–2021 (USD Million)
Table 20 Market Size, By Enduser
Table 21 Market in Pharmaceutical and Biotechnology Companies, By Geography, 2014-2021 (USD Million)
Table 22 Market in Research Laboratories and Institutes, By Geography, 2014-2021 (USD Million)
Table 23 Market in Hospitals and Diagnostic Centers, By Geography, 2014-2021 (USD Million)
Table 24 North America Market, By Country, 2014-2021 (USD Million)
Table 25 North America Market, By Technology, 2014-2021 (USD Million)
Table 26 North America Market, By Application, 2014-2021 (USD Million)
Table 27 U.S. Market, By Technology, 2014-2021 (USD Million)
Table 28 U.S. Market, By Application, 2014–2021 (USD Billion)
Table 29 U.S. Regenerative Medicines Market, By End User, 2014–2021 (USD Million)
Table 30 Canada Market, By Technology, 2014-2021 (USD Million)
Table 31 Canada Cell-Based Products Market, By Enduser, 2014–2021 (USD Billion)
Table 32 Canada Market, By Application, 2014–2021 (USD Billion)
Table 33 Europe Regenerative Medicines Market, By Geography, 2014–2021 (USD Billion)
Table 34 Europe Market, By Technology, 2014-2021 (USD Million)
Table 35 Europe Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 36 Europe Market, By Application, 2014–2021 (USD Billion)
Table 37 Germany Market, By Technology, 2014-2021 (USD Million)
Table 38 Germany Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 39 Germany Market, By Application, 2014–2021 (USD Billion)
Table 40 UK Market, By Technology, 2014-2021 (USD Million)
Table 41 UK Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 42 UK Regenerative Medicines Market, By Application, 2014–2021 (USD Billion)
Table 43 France Market, By Technology, 2014-2021 (USD Million)
Table 44 France Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 45 France Market, By Application, 2014–2021 (USD Billion)
Table 46 Italy Market, By Technology, 2014-2021 (USD Million)
Table 47 Italy Cell-Based Products Market, By Enduser, 2014–2021 (USD Billion)
Table 48 Italy Market, By Application, 2014–2021 (USD Billion)
Table 49 Spain Market, By Technology, 2014-2021 (USD Million)
Table 50 Spain Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 51 Spain Market, By Application, 2014–2021 (USD Billion)
Table 52 Rest of Europe(RoE) Regenerative Medicines Market, By Technology, 2014–2021 (USD Billion)
Table 53 Rest of Europe(RoE) Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 54 Rest of Europe (RoE) Regenerative Medicines Market, By Application, 2014–2021 (USD Billion)
Table 55 Asia-Pacific Regenerative Medicines Market, By Country, 2014–2021 (USD Billion)
Table 56 Asia-Pacific Market, By Technology, 2014-2021 (USD Million)
Table 57 Asia-Pacific Market, By Application, 2014–2021 (USD Billion)
Table 58 Asia-Pacific Regenerative Medicines Market, By End User, 2013–2021 (USD Billion)
Table 59 RoW Market, By Technology, 2014-2021 (USD Million)
Table 60 RoW Cell-Based Products Market, By End User, 2014–2021 (USD Billion)
Table 61 RoW Market, By Application, 2014–2021 (USD Billion)
Table 62 New Product Launches, 2013–2016
Table 63 Acquisitions, 2014–2016
Table 64 Regulatory Approvals, 2013–2016
Table 65 Partnerships, 2016
Table 66 Agreements, 2013–2016

List of Figures (72 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation Methodology: Bottom-Up Approach
Figure 3 Market Size Estimation Methodology: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Global Market to Witness High Growth Rate During the Forecast Period
Figure 7 Scaffold Based Technology Dominates the Market
Figure 8 Market Segmentation
Figure 9 Market Segmentation, By Technology
Figure 10 Market Segmentation, By Application
Figure 11 Market Segmentation, By End User
Figure 12 Market Segmentation, By Region
Figure 13 Drivers, Restraints, Opportunities, and Challenges
Figure 14 Scaffold Based Technology Segment Dominated the Market
Figure 15 North America Accounted for the Largest Share of Global Market for Scaffold Based Technology Segment
Figure 16 Drivers, Restraints, Opportunities, and Challenges
Figure 17 Hydropgels/Ecm Analogs Accounted for the Largest Share of Scaffold Based Market
Figure 18 North America Accounted for the Largest Share of the Global 3D Cell Culure Marketfor Scaffold Based Technology
Figure 19 Europe is the Fastest Grwoing Regionin the Scaffold Based Market for Solid Scaffold Technology in 2015
Figure 20 Europe Dominated the Scaffold Based Market for Micropatterened Surfaces
Figure 21 Hanging Drop Plates is the Fastest Growing Segment of Scaffold Free Technology in Market
Figure 22 North America is the Fastest Growing Region in the Global Market for Scaffold Free Technology
Figure 23 Cancer Cell Research to Dominate the Market in 2015
Figure 24 North America to Command the Largest Share of Market for Cancer Cell Research in 2015
Figure 25 North America to Command the Largest Share of Market for Cell Based Research in 2015
Figure 26 North America to Command the Largest Share of Market for Regenrative Medicine in 2015
Figure 27 Market Size, By Application, 2014-2021
Figure 28 Market Size, By Enduser
Figure 29 Market in Pharmaceutical and Biotechnology Companies, By Geography, 2014-2021 (USD Million)
Figure 30 Market in Hospitals and Diagnostic Centers, By Geography, 2014-2021 (USD Million)
Figure 31 Market Segmentation, By Application
Figure 32 Orthopedic & Musculoskeletal Spine Segment Dominated the Regenerative Medicine Application Market in 2015
Figure 33 North America Accounted for the Largest Share of the Global Regenerative Medicines Market for Orthopedic & Musculoskeletal Spine in 2015
Figure 34 North America Dominated the Regenerative Medicines Market for Dermatology in 2015
Figure 35 Asia-Pacific is the Fastest Growing Region in the Global Regenerative Medicines Market for Cardiovascular Applications
Figure 36 North America Dominated the Regenerative Medicines Market for Central Nervous System Applications in 2015
Figure 37 Asia-Pacific is the Fastest Growing Region in the Global Regenerative Medicines Market for Oncology Application
Figure 38 Asia-Pacific is the Fastest Growing Region in the Global Regenerative Medicines Market for Diabetes Application
Figure 39 North America Dominated the Regenerative Medicines Market for Other Applications in 2015
Figure 40 Europe 3D Cell Culture Snapshot
Figure 41 North America Regenerative Medicines Market Snapshot
Figure 42 Cell-Based Products Segment Accounted for the Largest Share of the North America Regenerative Medicines Market in 2015
Figure 43 Orthopedic & Musculoskeletal Spine Application Segment Accounted for the Largest Share of the North America Regenerative Medicines Market in 2015
Figure 44 Cell Therapy Segment Accounted for the Largest Share of the North America Regenerative Medicines Therapy Market in 2015
Figure 45 Cell-Based Products Segment Accounted for the Largest Share of the U.S. Regenerative Medicines Market in 2015
Figure 46 Orthopedic & Musculoskeletal Spine Application Segment Accounted for the Largest Share of the U.S. Regenerative Medicines Market in 2015
Figure 47 Cell Therapy Segment Accounted for the Largest Share of the U.S. Regenerative Medicines Therapy Market
Figure 48 Cell-Based Products Segment Accounted for the Largest Share of the Canada Regenerative Medicines Market in 2015
Figure 49 3D Cell Culture Market Size
Figure 50 3D Cell Culture Market to Grow at the Highest Rate (2016-2021)
Figure 51 North America 3D Culture Market Snapshot
Figure 52 U.S to Dominate the North American 3D Cell Culture Market in 2015
Figure 53 Among Applications, the Cancer Research Segment Accounted for the Largest Share in the Europe 3D Cell Culture Market in 2015
Figure 54 Germany Dominated the European 3D Cell Culture Market in 2015
Figure 55 Cancer Research Accounted for the Largest Share of the U.K. 3D Cell Culture Market in 2015
Figure 56 Asia-Pacific 3D Cell Culture Market Snapshot
Figure 57 Among Technology, Scaffold Based Segment Accounted for the Largest Share in the Asia-Pacific 3D Cell Culture Market in 2015
Figure 58 Among Applications, the Cancer Research Segment Accounted for the Largest Share in the Asia-Pacific 3D Cell Culture Market in 2015
Figure 59 Among End User Pharma and Biotechnology Companies Segment Accounted for the Largest Share in the Asia-Pacific 3D Cell Culture Market
Figure 60 The Scaffold Based Segment Accounted for the Largest Share in the RoW 3D Cell Culture Market in 2015
Figure 61 Among Applications, the Pharma and Biotechnology Companies Segment Accounted for the Largest Share in the RoW 3D Cell Culture Market in 2015
Figure 62 Leading Market Players Adopted Both Organic and Inorganic Growth Strategies Over the Last Four Years (2013–2016)
Figure 63 Global 3D Cell Culture Market Share Analysis, By Key Player, 2015
Figure 64 Battle for Market Share: New Product Launches & Product Enhancements is the Key Strategy
Figure 65 Geographic Revenue Snapshot (2015)
Figure 66 Thermo Fisher Scientific: Company Snapshot
Figure 67 BD: Company Snapshot
Figure 68 Corning Incorporated: Company Snapshot
Figure 69 Lonza AG: Company Snapshot
Figure 70 Sigma-Aldrich Co.LLC: Company Snapshot
Figure 71 Promocell GmbH.: Company Snapshot
Figure 72 3D Biotek LLC: Company Snapshot

【レポートのキーワード】

3D細胞培養、3D細胞培養技術、ハイドロゲル、足場、3Dバイオリアクター、磁気浮上、微少流体技術、バイオ技術、細胞アッセイ、3Dプリンティング